{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T22:04:58Z","timestamp":1787868298863,"version":"build-2784847793"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,1,3]],"date-time":"2021-01-03T00:00:00Z","timestamp":1609632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,3]],"date-time":"2021-01-03T00:00:00Z","timestamp":1609632000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacol. Rep"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s43440-020-00193-0","type":"journal-article","created":{"date-parts":[[2021,1,3]],"date-time":"2021-01-03T13:02:47Z","timestamp":1609678967000},"page":"891-906","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Synthesis, antitumor, antibacterial and urease inhibitory evaluation of new piperazinyl N-4 carbamoyl functionalized ciprofloxacin derivatives"],"prefix":"10.1007","volume":"73","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9352-8423","authenticated-orcid":false,"given":"Mohamed A. A.","family":"Abdel-Aal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Montaser Sh. A.","family":"Shaykoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gamal El-Din A. A.","family":"Abuo-Rahma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamdouh F. A.","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Badr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salah A.","family":"Abdel-Aziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,3]]},"reference":[{"key":"193_CR1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0924-8579(00)00192-8","volume":"16","author":"P Appelbaum","year":"2000","unstructured":"Appelbaum P, Hunter P. The fluoroquinolone antibacterials: past, present and future perspectives. Int J Antimicrob Agents. 2000;16:5\u201315.","journal-title":"Int J Antimicrob Agents"},{"key":"193_CR2","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.2165\/00003495-200767140-00007","volume":"67","author":"S Moadebi","year":"2007","unstructured":"Moadebi S, Harder CK, Fitzgerald MJ, Elwood KR, Marra F. Fluoroquinolones for the treatment of pulmonary tuberculosis. Drugs. 2007;67:2077\u201399.","journal-title":"Drugs"},{"key":"193_CR3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.diagmicrobio.2007.01.020","volume":"58","author":"RN Jones","year":"2007","unstructured":"Jones RN, Fritsche TR, Sader HS, Stilwell MG. Activity of garenoxacin, an investigational des-F (6)-quinolone, tested against pathogens from community-acquired respiratory tract infections, including those with elevated or resistant-level fluoroquinolone MIC values. Diagn Microbiol Infect Dis. 2007;58:9\u201317.","journal-title":"Diagn Microbiol Infect Dis"},{"key":"193_CR4","doi-asserted-by":"crossref","first-page":"731","DOI":"10.2165\/11207380-000000000-00000","volume":"71","author":"GM Keating","year":"2011","unstructured":"Keating GM. Sitafloxacin. Drugs. 2011;71:731\u201344.","journal-title":"Drugs"},{"key":"193_CR5","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1016\/j.bmc.2007.01.051","volume":"15","author":"A Imramovsk\u00fd","year":"2007","unstructured":"Imramovsk\u00fd A, Polanc S, Vin\u0161ov\u00e1 J, Ko\u010devar M, Jamp\u00edlek J, Re\u010dkov\u00e1 Z, et al. A new modification of anti-tubercular active molecules. Biorg Med Chem. 2007;15:2551\u20139.","journal-title":"Biorg Med Chem"},{"key":"193_CR6","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1158\/1078-0432.CCR-09-2236","volume":"16","author":"RH Advani","year":"2010","unstructured":"Advani RH, Hurwitz HI, Gordon MS, Ebbinghaus SW, Mendelson DS, Wakelee HA, et al. Voreloxin, a first-in-class anticancer quinolone derivative, in relapsed\/refractory solid tumors: a report on two dosing schedules. Clin Cancer Res. 2010;16:2167\u201375.","journal-title":"Clin Cancer Res"},{"key":"193_CR7","doi-asserted-by":"crossref","first-page":"e1004562","DOI":"10.1371\/journal.ppat.1004562","volume":"11","author":"LM Harris","year":"2015","unstructured":"Harris LM, Merrick CJ. G-quadruplexes in pathogens: a common route to virulence control? PLoS Pathog. 2015;11:e1004562.","journal-title":"PLoS Pathog"},{"key":"193_CR8","doi-asserted-by":"crossref","first-page":"3270","DOI":"10.1093\/nar\/gky187","volume":"46","author":"E Ruggiero","year":"2018","unstructured":"Ruggiero E, Richter SN. G-quadruplexes and G-quadruplex ligands: targets and tools in antiviral therapy. Nucleic Acids Res. 2018;46:3270\u201383.","journal-title":"Nucleic Acids Res"},{"key":"193_CR9","doi-asserted-by":"crossref","first-page":"e1800376","DOI":"10.1002\/ardp.201800376","volume":"352","author":"MAA Abdel-Aal","year":"2019","unstructured":"Abdel-Aal MAA, Abdel-Aziz SA, Shaykoon MSA, Abuo-Rahma GE-DA. Towards anticancer fluoroquinolones: a review article. Arch Pharm. 2019;352:e1800376.","journal-title":"Arch Pharm"},{"key":"193_CR10","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ejmech.2013.08.040","volume":"69","author":"M Abdel-Aziz","year":"2013","unstructured":"Abdel-Aziz M, Park S-E, Abuo-Rahma GE-DA, Sayed MA, Kwon Y. Novel N-4-piperazinyl-ciprofloxacin-chalcone hybrids: synthesis, physicochemical properties, anticancer and topoisomerase i and ii inhibitory activity. Eur J Med Chem. 2013;69:427\u201338.","journal-title":"Eur J Med Chem"},{"key":"193_CR11","doi-asserted-by":"crossref","first-page":"439","DOI":"10.2174\/1568011033482279","volume":"3","author":"C Sissi","year":"2003","unstructured":"Sissi C, Palumbo M. The quinolone family: from antibacterial to anticancer agents. Curr Med Chem Anticancer Agents. 2003;3:439\u201350.","journal-title":"Curr Med Chem Anticancer Agents"},{"key":"193_CR12","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2174\/1381612013398013","volume":"7","author":"VE Anderson","year":"2001","unstructured":"Anderson VE, Osheroff N. Type II topoisomerases as targets for quinolone antibacterials turning Dr. Jekyll into Mr. Hyde. Curr Pharm Des. 2001;7:337\u201353.","journal-title":"Curr Pharm Des"},{"key":"193_CR13","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2174\/1568005043340920","volume":"4","author":"S Richter","year":"2004","unstructured":"Richter S, Parolin C, Palumbo M, Pal\u00f9 G. Antiviral properties of quinolone-based drugs. Curr Drug Targets Infect Disord. 2004;4:111\u20136.","journal-title":"Curr Drug Targets Infect Disord"},{"key":"193_CR14","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/aps.2011.158","volume":"33","author":"Z-y Shi","year":"2012","unstructured":"Shi Z-y, Li Y-q, Kang Y-h, Hu G-q, Huang-Fu C-s, Deng J-b, et al. Piperonal ciprofloxacin hydrazone induces growth arrest and apoptosis of human hepatocarcinoma SMMC-7721 cells. Acta Pharmacol Sin. 2012;33:271\u20138.","journal-title":"Acta Pharmacol Sin"},{"key":"193_CR15","first-page":"298","volume":"43","author":"G Hu","year":"2012","unstructured":"Hu G, Hou L, Wang G, Duan N, Wen X, Cao T. Synthesis and antitumor and antibacterial activities of fluoroquinolone C-3 isosteres I. Norfloxacin C-3 carbonylhydrazone derivatives. J China Pharm Univ. 2012;43:298\u2013301.","journal-title":"J China Pharm Univ"},{"key":"193_CR16","first-page":"35","volume":"44","author":"Q Xu","year":"2013","unstructured":"Xu Q, Hou L, Wu X. Synthesis and antitumor activity of ciprofloquinolone bis-(C3\/C7 hydrazone)s. J China Pharm Univ. 2013;44:35\u20138.","journal-title":"J China Pharm Univ"},{"key":"193_CR17","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1136\/jcp.2009.072595","volume":"63","author":"C Follmer","year":"2010","unstructured":"Follmer C. Ureases as a target for the treatment of gastric and urinary infections. J Clin Pathol. 2010;63:424\u201330.","journal-title":"J Clin Pathol"},{"key":"193_CR18","doi-asserted-by":"crossref","first-page":"e1004062","DOI":"10.1371\/journal.ppat.1004062","volume":"10","author":"JC Rutherford","year":"2014","unstructured":"Rutherford JC. The emerging role of urease as a general microbial virulence factor. PLoS Pathog. 2014;10:e1004062.","journal-title":"PLoS Pathog"},{"key":"193_CR19","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/1471-2180-11-183","volume":"11","author":"TF Murphy","year":"2011","unstructured":"Murphy TF, Brauer AL. Expression of urease by Haemophilus influenzae during human respiratory tract infection and role in survival in an acid environment. BMC Microbiol. 2011;11:183.","journal-title":"BMC Microbiol"},{"key":"193_CR20","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.ecoleng.2009.02.006","volume":"36","author":"W De Muynck","year":"2010","unstructured":"De Muynck W, De Belie N, Verstraete W. Microbial carbonate precipitation in construction materials: a review. Ecol Eng. 2010;36:118\u201336.","journal-title":"Ecol Eng"},{"key":"193_CR21","first-page":"37","volume":"6","author":"AI Omoregie","year":"2016","unstructured":"Omoregie AI, Senian N, Li PY, Hei NL, Leong DOE, Ginjom IRH, et al. Screening for urease-producing bacteria from limestone caves of sarawak. Born J Res Sci Technol. 2016;6:37\u201345.","journal-title":"Born J Res Sci Technol"},{"key":"193_CR22","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1080\/07391102.2000.10506568","volume":"17","author":"M Zimmer","year":"2000","unstructured":"Zimmer M. Molecular mechanics evaluation of the proposed mechanisms for the degradation of urea by urease. J Biomol Struct Dyn. 2000;17:787\u201397.","journal-title":"J Biomol Struct Dyn"},{"key":"193_CR23","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S0923-2508(02)01380-3","volume":"153","author":"M Mollenhauer-Rektorschek","year":"2002","unstructured":"Mollenhauer-Rektorschek M, Hanauer G, Sachs G, Melchers K. Expression of UreI is required for intragastric transit and colonization of gerbil gastric mucosa by Helicobacter pylori. Res Microbiol. 2002;153:659\u201366.","journal-title":"Res Microbiol"},{"key":"193_CR24","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/j.1365-2958.1993.tb01220.x","volume":"9","author":"CM Collins","year":"1993","unstructured":"Collins CM, D\u2019Orazio SE. Bacterial ureases: structure, regulation of expression and role in pathogenesis. Mol Microbiol. 1993;9:907\u201313.","journal-title":"Mol Microbiol"},{"key":"193_CR25","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jare.2018.01.006","volume":"13","author":"DY Graham","year":"2018","unstructured":"Graham DY, Miftahussurur M. Helicobacter pylori urease for diagnosis of Helicobacter pylori infection: a mini review. J Adv Res. 2018;13:51\u20137.","journal-title":"J Adv Res"},{"key":"193_CR26","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/jam.12241","volume":"115","author":"N Irwin","year":"2013","unstructured":"Irwin N, McCoy C, Carson L. Effect of pH on the in vitro susceptibility of planktonic and biofilm-grown P roteus mirabilis to the quinolone antimicrobials. J Appl Microbiol. 2013;115:382\u20139.","journal-title":"J Appl Microbiol"},{"key":"193_CR27","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1128\/IAI.68.2.443-448.2000","volume":"68","author":"GM Cox","year":"2000","unstructured":"Cox GM, Mukherjee J, Cole GT, Casadevall A, Perfect JR. Urease as a virulence factor in experimental cryptococcosis. Infect Immun. 2000;68:443\u20138.","journal-title":"Infect Immun"},{"key":"193_CR28","doi-asserted-by":"crossref","first-page":"789","DOI":"10.2174\/138920312804871094","volume":"13","author":"I Konieczna","year":"2012","unstructured":"Konieczna I, Zarnowiec P, Kwinkowski M, Kolesinska B, Fraczyk J, Kaminski Z, et al. Bacterial urease and its role in long-lasting human diseases. Curr Protein Pept Sci. 2012;13:789\u2013806.","journal-title":"Curr Protein Pept Sci"},{"key":"193_CR29","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1248\/bpb.22.1141","volume":"22","author":"TC RhO","year":"1999","unstructured":"RhO TC, Bae E-A, Kim D-H, Oh WK, Kim BY, Ahn JS, et al. Anti-Helicobacter pylori acticvity of quinolone alkaloids from evodiae fructus. Biol Pharm Bull. 1999;22:1141\u20133.","journal-title":"Biol Pharm Bull"},{"key":"193_CR30","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1093\/infdis\/171.2.483","volume":"171","author":"M Ramadan","year":"1995","unstructured":"Ramadan M, Tawfik A, El-Kersh T, Shibl A. In vitro activity of subinhibitory concentrations of quinolones on urea-splitting bacteria: effect on urease activity and on cell surface hydrophobicity. J Infect Dis. 1995;171:483\u20136.","journal-title":"J Infect Dis"},{"key":"193_CR31","first-page":"81","volume":"4","author":"MA Abdullah","year":"2016","unstructured":"Abdullah MA, El-Baky RMA, Hassan HA, Abdelhafez E-SM, Abuo-Rahma GE-DA. Fluoroquinolones as urease inhibitors: anti-Proteus mirabilis activity and molecular docking studies. Am J Microbiol Res. 2016;4:81\u20134.","journal-title":"Am J Microbiol Res"},{"key":"193_CR32","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/306385","author":"S Gul","year":"2013","unstructured":"Gul S, Sultana N, Arayne MS, Shamim S, Akhtar M, Khan A. Sparfloxacin-metal complexes as urease inhibitors: their synthesis, characterization, antimicrobial, and antienzymatic evaluation. J Chem. 2013. https:\/\/doi.org\/10.1155\/2013\/306385.","journal-title":"J Chem"},{"key":"193_CR33","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3390\/molecules21040411","volume":"21","author":"M Nisar","year":"2016","unstructured":"Nisar M, Khan S, Qayum M, Khan A, Farooq U, Jaafar H, et al. Robust synthesis of ciprofloxacin-capped metallic nanoparticles and their urease inhibitory assay. Molecules. 2016;21:411.","journal-title":"Molecules"},{"key":"193_CR34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bioorg.2016.11.002","volume":"70","author":"MA Abdullah","year":"2017","unstructured":"Abdullah MA, Abuo-Rahma GE-DA, Abdelhafez E-SM, Hassan HA, El-Baky RMA. Design, synthesis, molecular docking, anti-Proteus mirabilis and urease inhibition of new fluoroquinolone carboxylic acid derivatives. Bioorg Chem. 2017;70:1\u201311.","journal-title":"Bioorg Chem"},{"key":"193_CR35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.21608\/jmr.2019.12650.1001","volume":"1","author":"MAA Abdel-Aal","year":"2019","unstructured":"Abdel-Aal MAA, Abdel-Aziz SA, Shaykoon MSA, Mohamed MF, Abuo-Rahma GE-DA. Antibacterial and urease inhibitory activity of new piperazinyl N-4 functionalized ciprofloxacin-oxadiazoles. J Modern Res. 2019;1:1\u20137.","journal-title":"J Modern Res"},{"key":"193_CR36","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/88563","volume":"8","author":"N-C Ha","year":"2001","unstructured":"Ha N-C, Oh S-T, Sung JY, Cha KA, Lee MH, Oh B-H. Supramolecular assembly and acid resistance of Helicobacter pylori urease. Nat Struct Mol Biol. 2001;8:505\u20139.","journal-title":"Nat Struct Mol Biol"},{"key":"193_CR37","doi-asserted-by":"crossref","first-page":"6267","DOI":"10.1016\/S0040-4039(98)01330-6","volume":"39","author":"RA Batey","year":"1998","unstructured":"Batey RA, Santhakumar V, Yoshina-Ishii C, Taylor SD. An efficient new protocol for the formation of unsymmetrical tri-and tetrasubstituted ureas. Tetrahedron Lett. 1998;39:6267\u201370.","journal-title":"Tetrahedron Lett"},{"key":"193_CR38","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1021\/ac60252a045","volume":"39","author":"M Weatherburn","year":"1967","unstructured":"Weatherburn M. Phenol-hypochlorite reaction for determination of ammonia. Anal Chem. 1967;39:971\u20134.","journal-title":"Anal Chem"},{"key":"193_CR39","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.bioorg.2018.10.070","volume":"83","author":"M Khan","year":"2019","unstructured":"Khan M, Khan KM, Parveen S, Shaikh M, Fatima N, Choudhary MI. Syntheses, in vitro urease inhibitory activities of urea and thiourea derivatives of tryptamine, their molecular docking and cytotoxic studies. Bioorg Chem. 2019;83:595\u2013610.","journal-title":"Bioorg Chem"},{"key":"193_CR40","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1080\/14756360600774470","volume":"21","author":"M Ayaz","year":"2006","unstructured":"Ayaz M, Lodhi MA, Riaz M, Ul-haq A, Malik A, Choudhary MI. Novel urease inhibitors from Daphne oleoids. J Enzyme Inhib Med Chem. 2006;21:527\u20139.","journal-title":"J Enzyme Inhib Med Chem"},{"key":"193_CR41","doi-asserted-by":"crossref","first-page":"12382","DOI":"10.1021\/ja204488p","volume":"133","author":"SS Jalisatgi","year":"2011","unstructured":"Jalisatgi SS, Kulkarni VS, Tang B, Houston ZH, Lee MW Jr, Hawthorne MF. A convenient route to diversely substituted icosahedral closomer nanoscaffolds. J Am Chem Soc. 2011;133:12382\u20135.","journal-title":"J Am Chem Soc"},{"key":"193_CR42","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.1016\/j.ejmech.2009.04.006","volume":"44","author":"B Jayashankar","year":"2009","unstructured":"Jayashankar B, Rai KL, Baskaran N, Sathish H. Synthesis and pharmacological evaluation of 1, 3, 4-oxadiazole bearing bis (heterocycle) derivatives as anti-inflammatory and analgesic agents. Eur J Med Chem. 2009;44:3898\u2013902.","journal-title":"Eur J Med Chem"},{"key":"193_CR43","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/17518250902922798","volume":"2","author":"A Thomas","year":"2009","unstructured":"Thomas A, Tupe P, Badhe R, Nanda R, Kothapalli L, Paradkar O, et al. Green route synthesis of Schiff\u2019s bases of isonicotinic acid hydrazide. Green Chem Lett Rev. 2009;2:23\u20137.","journal-title":"Green Chem Lett Rev"},{"key":"193_CR44","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/ddr.430340203","volume":"34","author":"MR Boyd","year":"1995","unstructured":"Boyd MR, Paull KD. Some practical considerations and applications of the National Cancer Institute in vitro anticancer drug discovery screen. Drug Dev Res. 1995;34:91\u2013109.","journal-title":"Drug Dev Res"},{"key":"193_CR45","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2174\/1874104501711010081","volume":"11","author":"SL El-Ansary","year":"2017","unstructured":"El-Ansary SL, Rahman DEA, Ghany LMA. Synthesis and anticancer evaluation of some new 3-benzyl-4, 8-dimethylbenzopyrone derivatives. Open Med Chem J. 2017;11:81\u201391.","journal-title":"Open Med Chem J"},{"key":"193_CR46","first-page":"622","volume":"19","author":"MR Grever","year":"1992","unstructured":"Grever MR, Schepartz SA, Chabner BA. The National Cancer Institute: cancer drug discovery and development program. Semin Oncol. 1992;19:622\u201338.","journal-title":"Semin Oncol"},{"key":"193_CR47","first-page":"179","volume":"79","author":"DML Morgan","year":"1998","unstructured":"Morgan DML. Tetrazolium (MTT) assay for cellular viability and activity. Methods Mol Biol. 1998;79:179\u201384.","journal-title":"Methods Mol Biol"},{"key":"193_CR48","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1590\/S1517-83822007000200034","volume":"38","author":"C Valgas","year":"2007","unstructured":"Valgas C, Souza SM, Sm\u00e2nia EF, Sm\u00e2nia A. Screening methods to determine antibacterial activity of natural products. Braz J Microbiol. 2007;38:369\u201380.","journal-title":"Braz J Microbiol"},{"key":"193_CR49","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3998\/ark.5550190.0010.720","volume":"7","author":"M Serwar","year":"2009","unstructured":"Serwar M, Akhtar T, Hameed S, Khan KM. Synthesis, urease inhibition and antimicrobial activities of some chiral 5-aryl-4-(1-phenylpropyl)-2H-1, 2, 4-triazole-3 (4H)-thiones. Arkivoc. 2009;7:210\u201321.","journal-title":"Arkivoc"},{"key":"193_CR50","unstructured":"Molecular Operating Environment (MOE), Version 2008. 10, Chemical Computing Group, Inc. Montreal, Quebec, Canada. http:\/\/www.chemcomp.com."}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-020-00193-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43440-020-00193-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-020-00193-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,7]],"date-time":"2021-06-07T02:12:05Z","timestamp":1623031925000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43440-020-00193-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,3]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["193"],"URL":"https:\/\/doi.org\/10.1007\/s43440-020-00193-0","relation":{},"ISSN":["1734-1140","2299-5684"],"issn-type":[{"value":"1734-1140","type":"print"},{"value":"2299-5684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,3]]},"assertion":[{"value":"8 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 January 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}